NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 12, 2020 4:05 PM ESTRevenue increased 34% versus prior year Avenova® unit sales set quarterly record Exited Q3 with $13.4 million in cash and equivalents Regained compliance with NYSE American continued-listing standards Launches CelleRx® Clinical Reset into beauty market
Conference call begins at 4:30 p.m. Eastern time today
EMERYVILLE, Calif.--(BUSINESS... More
